MLYS Mineralys Therapeutics, Inc.
Nasdaq · SEC CIK 1933414 · EDGAR
- Bought, last 12 months
- $8.76M 1 purchases by 1 insiders
- Sold, last 12 months
- $87.64M 43 sales by 8 insiders
- Filings on record
- 159 since 2023-02-13, latest 2026-09-24 21:49
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Catalys Pacific Fund, LP | 10% | — | $43.35M |
| Congleton Jon | CEO, Dir | — | $14.91M |
| Rodman David Malcom | Chief Medical Off | — | $14.41M |
| Shah Rajeev M. | Dir | $8.76M | — |
| Levy Adam Scott | CFO, Sec | — | $6.16M |
| Warren Eric | Chief Commercial Off | — | $3.30M |
| Slingsby Brian Taylor | Dir, 10% | — | $3.01M |
| Gold Alexander M | Dir | — | $1.58M |
| Karydas Daphne | Dir | — | $925.6K |
| DiRocco Derek | Dir | — | — |
Transactions 166
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-09-24 21:49 | 2026-09-22 | MLYS | Slingsby Brian Taylor | Dir | S - Sale | $28.81 | -104.3K | 7.81M | -1% | -$3.01M |
| DT | 2026-09-22 18:48 | 2026-09-21 | MLYS | Warren Eric | Chief Commercial Off | M - OptEx | $13.24 | +7,438 | 45.8K | +19% | +$98.5K |
| DT | 2026-09-22 18:48 | 2026-09-21 | MLYS | Warren Eric | Chief Commercial Off | S - Sale+OE | $28.12 | -7,438 | 38.4K | -16% | -$209.1K |
| DT | 2026-09-17 17:41 | 2026-09-15 | MLYS | Karydas Daphne | Dir | M - OptEx | $12.02 | +3,000 | 9,200 | +48% | +$36.1K |
| DT | 2026-09-17 17:41 | 2026-09-15 | MLYS | Karydas Daphne | Dir | S - Sale+OE | $28.58 | -3,000 | 6,200 | -33% | -$85.7K |
| DT | 2026-08-25 17:16 | 2026-08-21 | MLYS | Warren Eric | Chief Commercial Off | M - OptEx | $13.24 | +7,437 | 45.8K | +19% | +$98.5K |
| DT | 2026-08-25 17:16 | 2026-08-21 | MLYS | Warren Eric | Chief Commercial Off | S - Sale+OE | $25.98 | -7,437 | 38.4K | -16% | -$193.2K |
| D | 2026-08-12 19:33 | 2026-08-10 | MLYS | Ferguson James J. III | Chief Medical Off | A - Grant | $0.00 | +102.4K | 102.4K | New | $0 |
| DT | 2026-08-12 19:33 | 2026-08-10 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $16.00 | +2,170 | 53.6K | +4% | +$34.7K |
| DT | 2026-08-12 19:33 | 2026-08-10 | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $27.09 | -2,170 | 51.4K | -4% | -$58.8K |
| DT | 2026-07-23 18:39 | 2026-07-21 | MLYS | Warren Eric | Chief Commercial Off | M - OptEx | $13.24 | +7,438 | 45.8K | +19% | +$98.5K |
| DT | 2026-07-23 18:39 | 2026-07-21 | MLYS | Warren Eric | Chief Commercial Off | S - Sale+OE | $26.87 | -7,438 | 38.4K | -16% | -$199.9K |
| DT | 2026-07-20 21:00 | 2026-07-17 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $15.44 | +416 | 51.8K | +0.8% | +$6,423 |
| DT | 2026-07-20 21:00 | 2026-07-17 | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $26.53 | -416 | 51.4K | -0.8% | -$11.0K |
| T | 2026-07-15 20:58 | 2026-07-13 | MLYS | Congleton Jon | CEO, Dir | S - Sale | $27.24 | -10.7K | 603.6K | -2% | -$291.4K |
| DMT | 2026-07-15 20:58 | 2026-07-13 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $7.28 | +14.1K | 71.8K | +24% | +$102.4K |
| DMT | 2026-07-15 20:58 | 2026-07-13+ | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $27.28 | -20.4K | 51.4K | -28% | -$556.7K |
| DT | 2026-07-10 19:15 | 2026-07-09 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $16.00 | +2,171 | 59.9K | +4% | +$34.7K |
| DT | 2026-07-10 19:15 | 2026-07-09 | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $30.30 | -2,171 | 57.7K | -4% | -$65.8K |
| MT | 2026-06-30 18:41 | 2026-06-30 | MLYS | Congleton Jon | CEO, Dir | S - Sale | $26.14 | -75.0K | 614.3K | -11% | -$1.96M |
| DT | 2026-06-30 18:41 | 2026-06-26 | MLYS | Warren Eric | Chief Commercial Off | M - OptEx | $13.24 | +104.1K | 142.5K | +271% | +$1.38M |
| DT | 2026-06-30 18:41 | 2026-06-26 | MLYS | Warren Eric | Chief Commercial Off | S - Sale+OE | $25.90 | -104.1K | 38.4K | -73% | -$2.70M |
| DMT | 2026-06-17 21:18 | 2026-06-15+ | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $12.55 | +8,126 | 61.7K | +15% | +$101.9K |
| DMT | 2026-06-17 21:18 | 2026-06-15+ | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $24.19 | -14.5K | 57.1K | -20% | -$350.1K |
| DT | 2026-06-17 21:18 | 2026-06-17 | MLYS | Karydas Daphne | Dir | M - OptEx | $12.02 | +3,000 | 9,200 | +48% | +$36.1K |
| DT | 2026-06-17 21:18 | 2026-06-17 | MLYS | Karydas Daphne | Dir | S - Sale+OE | $25.00 | -3,000 | 6,200 | -33% | -$75.0K |
| DMT | 2026-06-12 18:04 | 2026-06-10+ | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $4.88 | +8,519 | 69.8K | +14% | +$41.6K |
| DMT | 2026-06-12 18:04 | 2026-06-10+ | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $24.20 | -8,519 | 63.4K | -12% | -$206.2K |
| DT | 2026-05-19 19:15 | 2026-05-18 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $15.44 | +417 | 63.9K | +0.7% | +$6,438 |
| DT | 2026-05-19 19:15 | 2026-05-18 | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $27.55 | -417 | 63.4K | -0.7% | -$11.5K |
| DMT | 2026-05-13 21:42 | 2026-05-11+ | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $8.45 | +16.2K | 77.5K | +26% | +$137.1K |
| DMT | 2026-05-13 21:42 | 2026-05-11+ | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $28.91 | -22.6K | 63.4K | -26% | -$652.6K |
| DT | 2026-04-21 18:59 | 2026-04-17 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $15.44 | +416 | 70.2K | +0.6% | +$6,423 |
| DT | 2026-04-21 18:59 | 2026-04-17 | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $31.33 | -416 | 69.8K | -0.6% | -$13.0K |
| DMT | 2026-04-15 21:45 | 2026-04-13 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $7.28 | +14.1K | 90.2K | +18% | +$102.4K |
| DMT | 2026-04-15 21:45 | 2026-04-13+ | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $26.89 | -20.4K | 69.8K | -23% | -$548.7K |
| T | 2026-04-15 21:45 | 2026-04-13 | MLYS | Congleton Jon | CEO, Dir | S - Sale | $26.83 | -15.7K | 689.3K | -2% | -$422.0K |
| DT | 2026-04-13 21:13 | 2026-04-09 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $16.00 | +2,170 | 78.3K | +3% | +$34.7K |
| DT | 2026-04-13 21:13 | 2026-04-09 | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $27.38 | -2,170 | 76.1K | -3% | -$59.4K |
| MT | 2026-04-02 18:54 | 2026-03-31 | MLYS | Congleton Jon | CEO, Dir | S - Sale | $26.27 | -75.0K | 705.1K | -10% | -$1.97M |
| DT | 2026-04-02 18:53 | 2026-03-31 | MLYS | Karydas Daphne | Dir | M - OptEx | $12.02 | +3,000 | 9,200 | +48% | +$36.1K |
| DT | 2026-04-02 18:53 | 2026-03-31 | MLYS | Karydas Daphne | Dir | S - Sale+OE | $25.00 | -3,000 | 6,200 | -33% | -$75.0K |
| MI | 2026-03-31 | 2026-03-27+ | MLYS | Shah Rajeev M. | Dir | P - Purchase | $23.75 | +369.0K | 5.83M | +7% | +$8.76M |
| D | 2026-03-17 | 2026-03-17 | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $25.65 | -417 | 76.1K | -0.5% | -$10.7K |
| D | 2026-03-17 | 2026-03-17 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $15.44 | +417 | 76.6K | +0.5% | +$6,438 |
| DM | 2026-03-16 | 2026-03-12+ | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $26.61 | -20.4K | 82.5K | -20% | -$543.0K |
| DM | 2026-03-16 | 2026-03-12+ | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $7.28 | +14.1K | 86.0K | +20% | +$102.4K |
| D | 2026-03-10 | 2026-03-09 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $16.00 | +2,171 | 84.7K | +3% | +$34.7K |
| D | 2026-03-10 | 2026-03-09 | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $26.84 | -2,171 | 82.5K | -3% | -$58.3K |
| D | 2026-02-20 | 2026-02-19 | MLYS | AKKARAJU SRINIVAS | Dir, 10% | A - Grant | $0.00 | +6,200 | 6,200 | New | $0 |
| D | 2026-02-20 | 2026-02-19 | MLYS | Slingsby Brian Taylor | Dir, 10% | J - Other | $0.00 | -6,200 | 0 | -100% | $0 |
| DI | 2026-02-20 | 2026-02-19 | MLYS | Slingsby Brian Taylor | Dir, 10% | J - Other | $0.00 | +6,200 | 7.91M | +0.1% | $0 |
| D | 2026-02-20 | 2026-02-19 | MLYS | Slingsby Brian Taylor | Dir, 10% | A - Grant | $0.00 | +6,200 | 6,200 | New | $0 |
| D | 2026-02-20 | 2026-02-19 | MLYS | Rodman David Malcom | Chief Medical Off | A - Grant | $0.00 | +38.4K | 82.5K | +87% | $0 |
| D | 2026-02-20 | 2026-02-19 | MLYS | Levy Adam Scott | CFO, Sec | A - Grant | $0.00 | +39.9K | 48.5K | +462% | $0 |
| D | 2026-02-20 | 2026-02-19 | MLYS | Gold Alexander M | Dir | A - Grant | $0.00 | +6,200 | 6,200 | New | $0 |
| D | 2026-02-20 | 2026-02-19 | MLYS | DiRocco Derek | Dir | A - Grant | $0.00 | +6,200 | 6,200 | New | $0 |
| D | 2026-02-20 | 2026-02-19 | MLYS | Congleton Jon | CEO, Dir | A - Grant | $0.00 | +140.9K | 780.1K | +22% | $0 |
| D | 2026-02-20 | 2026-02-19 | MLYS | SBLENDORIO GLENN | Dir | A - Grant | $0.00 | +6,200 | 6,200 | New | $0 |
| D | 2026-02-20 | 2026-02-19 | MLYS | Karydas Daphne | Dir | A - Grant | $0.00 | +6,200 | 6,200 | New | $0 |
| DI | 2026-02-20 | 2026-02-19 | MLYS | RA Capital Healthcare Fund LP | Dir | A - Grant | $0.00 | +6,200 | 6,200 | New | $0 |
| D | 2026-02-17 | 2026-02-17 | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $27.59 | -417 | 44.1K | -0.9% | -$11.5K |
| D | 2026-02-17 | 2026-02-17 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $15.44 | +417 | 44.5K | +0.9% | +$6,438 |
| DM | 2026-02-13 | 2026-02-12+ | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $27.93 | -20.4K | 51.0K | -29% | -$569.8K |
| DM | 2026-02-13 | 2026-02-12+ | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $7.28 | +14.1K | 56.8K | +33% | +$102.3K |
| D | 2026-02-11 | 2026-02-09 | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $30.21 | -2,171 | 50.4K | -4% | -$65.6K |
| D | 2026-02-11 | 2026-02-09 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $16.00 | +2,171 | 52.6K | +4% | +$34.7K |
| D | 2026-01-20 | 2026-01-20 | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $32.10 | -416 | 50.4K | -0.8% | -$13.4K |
| D | 2026-01-20 | 2026-01-20 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $15.44 | +416 | 50.9K | +0.8% | +$6,423 |
| DM | 2026-01-15 | 2026-01-13+ | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $32.67 | -19.1K | 50.4K | -27% | -$623.1K |
| DM | 2026-01-15 | 2026-01-13 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $12.39 | +7,709 | 65.3K | +13% | +$95.5K |
| DM | 2026-01-13 | 2026-01-09+ | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $4.88 | +8,518 | 64.0K | +15% | +$41.6K |
| DM | 2026-01-13 | 2026-01-09+ | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $32.56 | -8,518 | 61.8K | -12% | -$277.4K |
| M | 2026-01-13 | 2026-01-12 | MLYS | Congleton Jon | CEO, Dir | S - Sale | $32.62 | -16.2K | 639.2K | -2% | -$529.7K |
| 2026-01-13 | 2026-01-12 | MLYS | Levy Adam Scott | CFO, Sec | S - Sale | $32.14 | -10.8K | 8,638 | -55% | -$345.8K | |
| DM | 2026-01-06 | 2026-01-02+ | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $12.27 | +252.7K | 97.2K | New | +$3.10M |
| DM | 2026-01-06 | 2026-01-02+ | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $35.25 | -262.8K | 115.3K | -70% | -$9.26M |
| D | 2025-11-24 | 2025-11-21 | MLYS | Congleton Jon | CEO, Dir | M - OptEx | $0.54 | +24.1K | 655.4K | +4% | +$13.0K |
| I | 2025-11-21 | 2025-11-20 | MLYS | Catalys Pacific Fund, LP | 10% | S - Sale | $43.35 | -1.00M | 7.90M | -11% | -$43.35M |
| DM | 2025-11-13 | 2025-11-11+ | MLYS | Gold Alexander M | Dir | S - Sale+OE | $45.45 | -34.7K | 5,000 | -87% | -$1.58M |
| DM | 2025-11-13 | 2025-11-11+ | MLYS | Gold Alexander M | Dir | M - OptEx | $10.92 | +34.7K | 15.0K | New | +$378.6K |
| DM | 2025-11-13 | 2025-11-11 | MLYS | Levy Adam Scott | CFO, Sec | M - OptEx | $14.11 | +105.7K | 138.9K | +318% | +$1.49M |
| DM | 2025-11-13 | 2025-11-11 | MLYS | Levy Adam Scott | CFO, Sec | S - Sale+OE | $44.87 | -119.5K | 19.4K | -86% | -$5.36M |
| DM | 2025-11-13 | 2025-11-13 | MLYS | Karydas Daphne | Dir | S - Sale+OE | $45.99 | -15.0K | 4,885 | -75% | -$689.8K |
| D | 2025-11-13 | 2025-11-13 | MLYS | Karydas Daphne | Dir | M - OptEx | $10.20 | +15.0K | 15.0K | New | +$153.0K |
| M | 2025-11-13 | 2025-11-11 | MLYS | Congleton Jon | CEO, Dir | S - Sale | $45.44 | -200.0K | 818.5K | -20% | -$9.09M |
| 2025-10-15 | 2025-10-15 | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale | $43.01 | -10.4K | 71.2K | -13% | -$446.0K | |
| M | 2025-10-15 | 2025-10-13 | MLYS | Levy Adam Scott | CFO, Sec | S - Sale | $42.01 | -10.8K | 116.9K | -8% | -$452.0K |
| M | 2025-10-15 | 2025-10-13 | MLYS | Congleton Jon | CEO, Dir | S - Sale | $42.67 | -15.1K | 832.9K | -2% | -$644.3K |
| M | 2025-09-16 | 2025-09-15 | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale | $36.00 | -11.4K | 81.5K | -12% | -$409.3K |
| I | 2025-09-08 | 2025-09-04 | MLYS | RA CAPITAL MANAGEMENT, L.P. | Dir | P - Purchase | $25.50 | +1.18M | 5.46M | +27% | +$30.00M |
| I | 2025-09-08 | 2025-09-04 | MLYS | AKKARAJU SRINIVAS | Dir | P - Purchase | $25.50 | +588.2K | 588.2K | New | +$15.00M |
| D | 2025-08-14 | 2025-08-12 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $1.08 | +6,349 | 104.3K | +6% | +$6,857 |
| D | 2025-08-14 | 2025-08-13 | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $12.93 | -11.4K | 92.9K | -11% | -$146.9K |
| M | 2025-07-30 | 2025-07-28+ | MLYS | Levy Adam Scott | CFO, Sec | S - Sale | $14.62 | -73.7K | 132.9K | -36% | -$1.08M |
| 2025-07-15 | 2025-07-11 | MLYS | Congleton Jon | CEO, Dir | S - Sale | $14.51 | -15.9K | 846.4K | -2% | -$230.5K | |
| D | 2025-07-15 | 2025-07-14 | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $14.59 | -11.4K | 97.9K | -10% | -$165.8K |
| D | 2025-07-15 | 2025-07-14 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $1.08 | +6,349 | 109.3K | +6% | +$6,857 |
| 2025-07-15 | 2025-07-11 | MLYS | Levy Adam Scott | CFO, Sec | S - Sale | $14.45 | -10.8K | 206.6K | -5% | -$155.5K | |
| D | 2025-06-16 | 2025-06-13 | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $14.60 | -11.4K | 101.7K | -10% | -$165.9K |
Purchase Sale Sale after option exercise All abbreviations